Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®
Status:
Withdrawn
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the long-term treatment with Zomacton® for
pituitary short stature in children with insufficient growth hormone production and/or short
stature caused by Turner's syndrome.